{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:04:14Z","timestamp":1772802254622,"version":"3.50.1"},"reference-count":45,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ijmm.2016.2481","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T09:44:17Z","timestamp":1454665457000},"page":"556-564","source":"Crossref","is-referenced-by-count":11,"title":["Treatment with novel AP-1 and NF-\u03baB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis"],"prefix":"10.3892","volume":"37","author":[{"given":"MAGDY","family":"EL-SALHY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUO","family":"UMEZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"key20180107234235_b1-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2796.1997.00237.x","article-title":"Colonic endocrine cells in inflammatory bowel disease","volume":"242","author":"El-Salhy","year":"1997","journal-title":"J Intern Med"},{"key":"key20180107234235_b2-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s10620-012-2249-6","article-title":"Chromogranin A cell density as a diagnostic marker for lymphocytic colitis","volume":"57","author":"El-Salhy","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key20180107234235_b3-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.3748\/wjg.v18.i42.6070","article-title":"High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis","volume":"18","author":"El-Salhy","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20180107234235_b4-ijmm-37-03-0556","first-page":"603","article-title":"High chromogranin A cell density in the colon of patients with lymphocytic colitis","volume":"4","author":"El-Salhy","year":"2011","journal-title":"Mol Med Rep"},{"key":"key20180107234235_b5-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.crohns.2012.01.013","article-title":"Enteroendocrine cells in terminal ileal Crohn's disease","volume":"6","author":"Moran","year":"2012","journal-title":"J Crohn's Colitis"},{"key":"key20180107234235_b6-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.clnu.2012.08.024","article-title":"Crohn's disease affecting the small bowel is associated with reduced appetite and elevated levels of circulating gut peptides","volume":"32","author":"Moran","year":"2013","journal-title":"Clin Nutr"},{"key":"key20180107234235_b7-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/00365528309182104","article-title":"Gut hormones in inflammatory bowel disease","volume":"18","author":"Besterman","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"key20180107234235_b8-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/ijmm.2012.1222","article-title":"The role of peptide YY in gastrointestinal diseases and disorders (review)","volume":"31","author":"El-Salhy","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107234235_b9-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1248\/yakushi.128.1347","article-title":"Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone","volume":"128","author":"Hirotani","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"key20180107234235_b10-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2174\/156802607782340966","article-title":"NPY family of hormones: clinical relevance and potential use in gastrointestinal disease","volume":"7","author":"Vona-Davis","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"key20180107234235_b11-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0196-9781(01)00617-9","article-title":"Peptide YY in gastrointestinal disorders","volume":"23","author":"El-Salhy","year":"2002","journal-title":"Peptides"},{"key":"key20180107234235_b12-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2169\/internalmedicine1962.27.49","article-title":"Peptide YY abnormalities in patients with ulcerative colitis","volume":"27","author":"Tari","year":"1988","journal-title":"Jpn J Med"},{"key":"key20180107234235_b13-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ibd.20851","article-title":"Plasma chromogranin a in patients with inflammatory bowel disease","volume":"15","author":"Sciola","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key20180107234235_b14-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00712758","article-title":"Increased populations of endocrine cells in Crohn's ileitis","volume":"410","author":"Bishop","year":"1987","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"key20180107234235_b15-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/ctg.2012.8","article-title":"Serotonin and GI Disorders: an update on clinical and experimental studies","volume":"3","author":"Manocha","year":"2012","journal-title":"Clin Transl Gastroenterol"},{"key":"key20180107234235_b16-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1078\/0065-1281-00641","article-title":"Mast cells and inflammatory mediators in chronic ulcerative colitis","volume":"104","author":"Stoyanova","year":"2002","journal-title":"Acta Histochem"},{"key":"key20180107234235_b17-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02355052","article-title":"Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease","volume":"31","author":"Yamamoto","year":"1996","journal-title":"J Gastroenterol"},{"key":"key20180107234235_b18-ijmm-37-03-0556","first-page":"552","article-title":"Plasma somatostatin levels in ulcerative colitis","volume":"41","author":"Payer","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"key20180107234235_b19-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF02049408","article-title":"Distribution and quantification of somatostatin in inflammatory disease","volume":"35","author":"Watanabe","year":"1992","journal-title":"Dis Colon Rectum"},{"key":"key20180107234235_b20-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02552546","article-title":"Somatostatin in the idiopathic inflammatory bowel diseases","volume":"31","author":"Koch","year":"1988","journal-title":"Dis Colon Rectum"},{"key":"key20180107234235_b21-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2249.2010.04150.x","article-title":"Gut hormones: emerging role in immune activation and inflammation","volume":"161","author":"Khan","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key20180107234235_b22-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MOG.0b013e328331b69e","article-title":"Neuropeptides and inflammatory bowel disease","volume":"25","author":"Margolis","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"key20180107234235_b23-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bmcl.2011.11.045","article-title":"Synthesis and biological evaluation of molecular probes based on the 9-methylstreptimidone derivative DTCM-glutarimide","volume":"22","author":"Ota","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180107234235_b24-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/TP.0b013e31827b3d90","article-title":"Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway","volume":"95","author":"Shibasaki","year":"2013","journal-title":"Transplantation"},{"key":"key20180107234235_b25-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.crohns.2011.08.011","article-title":"A novel NF-\u03baB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice","volume":"6","author":"Funakoshi","year":"2012","journal-title":"J Crohn's Colitis"},{"key":"key20180107234235_b26-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/813804","article-title":"Amelioration of severe TNBS induced colitis by novel AP-1 and NF-\u03baB inhibitors in rats","volume":"2014","author":"El-Salhy","year":"2014","journal-title":"Scientific World Journal"},{"key":"key20180107234235_b27-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00011-011-0348-z","article-title":"Inhibition of macrophage activation and suppression of graft rejection by DTCM-Glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone","volume":"60","author":"Takeiri","year":"2011","journal-title":"Inflamm Res"},{"key":"key20180107234235_b28-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.bmcl.2009.01.107","article-title":"Synthesis and biological evaluation on novel analogs of 9-methylstreptimidone, an inhibitor of NF-kappaB","volume":"19","author":"Ishikawa","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180107234235_b29-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/01.tp.0000250548.13063.44","article-title":"Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin","volume":"82","author":"Ueki","year":"2006","journal-title":"Transplantation"},{"key":"key20180107234235_b30-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0960-894X(00)00114-1","article-title":"Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C","volume":"10","author":"Matsumoto","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180107234235_b31-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1016\/j.bmc.2010.07.018","article-title":"Facile synthesis of peptide-porphyrin conjugates: towards artificial catalase","volume":"18","author":"Umezawa","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"key20180107234235_b32-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3748\/wjg.v20.i9.2383","article-title":"Endocrine cells in the ileum of patients with irritable bowel syndrome","volume":"20","author":"El-Salhy","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180107234235_b33-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/mmr.2013.1320","article-title":"Low-Grade inflammation in the rectum of patients with sporadic irritable bowel syndrome","volume":"7","author":"El-Salhy","year":"2013","journal-title":"Mol Med Rep"},{"key":"key20180107234235_b34-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(95)90599-5","article-title":"Experimental models of inflammatory bowel disease","volume":"109","author":"Elson","year":"1995","journal-title":"Gastroenterology"},{"key":"key20180107234235_b35-ijmm-37-03-0556","first-page":"1341","article-title":"Animal models of ulcerative colitis and their application in drug research","volume":"7","author":"Low","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"key20180107234235_b36-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuropharm.2008.07.016","article-title":"Serotonin and GI clinical disorders","volume":"55","author":"Spiller","year":"2008","journal-title":"Neuropharmacology"},{"key":"key20180107234235_b37-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2008.09.016","article-title":"Monocyte migration: a novel effect and signaling pathways of catestatin","volume":"598","author":"Egger","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"key20180107234235_b38-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.regpep.2004.10.001","article-title":"Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release","volume":"126","author":"Feistritzer","year":"2005","journal-title":"Regul Pept"},{"key":"key20180107234235_b39-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.2002.tb04495.x","article-title":"Regulation of endothelial cell shape and barrier function by chromogranin A","volume":"971","author":"Ferrero","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"key20180107234235_b40-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/gut.2006.103226","article-title":"CD4+ T cell-mediated immunological control of enterochro-maffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection","volume":"56","author":"Wang","year":"2007","journal-title":"Gut"},{"key":"key20180107234235_b41-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1189\/jlb.0906544","article-title":"Nicotine and serotonin in immune regulation and inflammatory processes: a perspective","volume":"81","author":"Clo\u00ebz-Tayarani","year":"2007","journal-title":"J Leukoc Biol"},{"key":"key20180107234235_b42-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000049013","article-title":"Serotonin and immune response: effect of the amine on in vitro proliferation of rat lymphocytes","volume":"9","author":"Stefulj","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"key20180107234235_b43-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1189\/jlb.70.1.65","article-title":"Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis","volume":"70","author":"Betten","year":"2001","journal-title":"J Leukoc Biol"},{"key":"key20180107234235_b44-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.156.1.310","article-title":"Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro","volume":"156","author":"Laberge","year":"1996","journal-title":"J Immunol"},{"key":"key20180107234235_b45-ijmm-37-03-0556","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/sj.jid.5700824","article-title":"Serotonin activates human monocytes and prevents apoptosis","volume":"127","author":"Soga","year":"2007","journal-title":"J Invest Dermatol"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2016.2481\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T05:41:49Z","timestamp":1718343709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2016.2481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,5]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ijmm.2016.2481"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2016.2481","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}